Market Place
Sourcing Support
Aivita Licenses Skincare Formulations To Retailer LevEllis
02 Oct 2024 //
BUSINESSWIRE
AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024
05 Jan 2024 //
PR NEWSWIRE
AIVITA CEO Dr. Hans Keirstead to Keynote Panel and Present at Vaccine Congress
04 Apr 2023 //
PR NEWSWIRE
AIVITA finds personalised Covid-19 vaccine generates immune response
14 Sep 2021 //
CLINICALTRIALSARENA
AVITA`s Personalized Vaccine Kit Elicits Robust Immune Memory Response
13 Sep 2021 //
BIOSPACE
AIVITA`s Phase 2 Glioblastoma Trial Shows Improved Progression Free Survival
08 Jun 2021 //
PRNEWSWIRE
AIVITA Biomedical Completes Ph1 Study of Personalized COVID-19 Vaccine Candidate
25 Feb 2021 //
PRNEWSWIRE
AIVITA Biomedical Closes $25 Million Financing Round
29 Dec 2020 //
PRESS RELEASE
AIVITA Biomedical`s Phase 2 Glioblastoma Trial Shows Improved Progression
17 Nov 2020 //
PRNEWSWIRE
AIVITA Biomedical Completes Treatment of Patients in Phase 2 Clinical Trial
02 Nov 2020 //
PRNEWSWIRE
AIVITA Biomedical Publishes Review of GM-CSF History Rationale Vaccine Adjuvant
03 Aug 2020 //
PRNEWSWIRE
AIVITA Biomedical Presents Updates from Ongoing Ovarian Cancer and Glioblastoma
27 Apr 2020 //
BIOSPACE
AIVITA Biomedical Provides Update of Ongoing Phase 2 Glioblastoma
08 Apr 2020 //
BUSINESSWIRE
AIVITA Biomedical completes patient enrollment target in ph2 GBM trial
05 Feb 2020 //
PHARMABIZ
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.